Effectiveness of preoperative concurrent chemoradiation therapy (CCRT) for locally advanced adenocarcinoma of cervix

European Journal of Surgical Oncology

Volumn 35, Issue 7, 2009, Pages 768-772

  Shibata, K ^a   Kajiyama, H ^a   Yamamoto, E ^a   Terauchi, M ^a   Ino, K ^a   Nomura, S ^a   Nawa, A ^a   Kawai, M ^b   Kikkawa, F ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Obstetrics and Gynecology   (Japan)

Author keywords

Adenocarcinoma; Cervical cancer; Locally advanced; Preoperative concurrent chemoradiation therapy (CCRT)

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONCURRENT CHEMORADIATION THERAPY; CONTINUOUS INFUSION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 67349251511     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.07.002     Document Type: Article

References (28)

1. Zheng T., Holford T., Ma Z., et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 25 (1996) 252-258
2. Smith H.O., Tiffany M.F., Qualls C.R., and Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol 78 (2000) 97-105
3. Attanoos R., Nahar K., Bigrigg A., Roberts S., Newcombe R.G., and Ismail S.M. Primary adenocarcinoma of the cervix: a clinicopathologic study of prognostic variables in 55 cases. Int J Gynecol Cancer 5 (1995) 179-186
4. Quinn M.A. Adenocarcinoma of the cervix: are there arguments for a different treatment policy?. Curr Opin Obstet Gynecol 9 (1997) 21-24
5. Berek J.S., Hacker N.F., Fu Y.S., Sokale J.R., Leuchter R.C., and Lagasse L.D. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 65 (1985) 46-52
6. Moberg P.J., Einhorn N., Silfversward C., and Soderberg G. Adenocarcinoma of the uterine cervix. Cancer 57 (1986) 407-410
7. Grisaru D., Covens A., Chapman B., et al. Does histology influence prognosis in patients with early stage cervical carcinoma?. Cancer 92 (2001) 2999-3004
8. Keys H.M., Bundy B., Stehamn F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. N Engl J Med 15 (1999) 1154-1161
9. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 15 (1999) 1137-1143
10. Whitney C.W., Sause W., Bundt B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjuvant to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 17 (1999) 1339-1348
11. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 15 (1999) 1144-1153
12. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1614
13. Jurado M., Marincz-Monge R., Garcia-Foncillas J., Aristu J., Lopez-Garcia G., and Brugarolas A. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol 74 (1999) 30-37
14. Mancuso S., Smaniotto D., Benedcetti Panici P., et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78 (2000) 324-328
15. Distefano M., Ferrandina G., Smaniotto D., et al. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility. Oncology 67 (2004) 103-111
16. Shibata K., Kikkawa F., Suzuki Y., et al. Usefulness of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Obstet Invest 57 2 (2004) 93-99
17. Hopkins M.P., and Morley G.W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77 (1991) 912-917
18. Baalbergen A., Ewing-Graham P.C., Hop W.C.J., Struijk P., and Helmerhorst T.J.M. Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 92 (2004) 262-267
19. Berek J.S., Castaldo T.W., Hacker N.F., Petrilli E.S., Lagasse L.D., and Moore J.G. Adenocarcinoma of the uterine cervix. Cancer 48 (1981) 2734-2741
20. Milsom I., and Friberg L.G. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 52 (1983) 942-947
21. Vokes E.E., and Weichselbaum R.R. Concomitant chemoradiatiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8 (1990) 911-934
22. Lea J.S., Sheets E.E., Wenham R.M., et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol 84 1 (2002) 115-119
23. Chargui R., Damak T., Khomsi F., et al. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 194 (2006) 43-48
24. Ishikawa H., Nakanishi T., Inoue T., and Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 73 (1999) 42-46
25. Houvenaeghel G., Lelievre L., Gonzague-Casabianca L., et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 100 (2006) 338-343
26. Rose P.G., Adler L.P., Rodriguez M., Faulhaber P.F., Abdulkarim F.W., and Miraldi F. Position emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surging staging: a surgicopathologic study. J Clin Oncol 17 1 (1999) 41-45
27. Lin W.C., Hung Y.C., Yeh L.S., Kao C.H., Yen R.F., and Shen Y.Y. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph node metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89 1 (2003) 73-76
28. Belhocine T., Thille A., Fridman V., et al. Contribution of whole-body (18)FDG-PET imaging in the management of cervical cancer. Gynecol Oncol 87 (2002) 90-97